Serum lipid levels and dyslipidaemia prevalence among 2-10 year-old Northern Mexican children

PloS One
Maria del Mar BibiloniJosep A Tur

Abstract

The increase in overweight and obese children may be linked to increased rates of dyslipidaemia. The aim was to assess the prevalence of dyslipidaemia and associated risk factors among the Northern Mexican child population. Four hundred and fifty-one subjects aged between 2 and 10 (47.5% girls) took part in the Nuevo León State Survey of Nutrition and Health 2011-2012. According to the 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, serum lipid levels (mg/dL) were categorized into three subgroups (acceptable, borderline-high/low or high/low) as follows: TChol: acceptable <170, borderline-high 170-199, high ≥200; LDL-chol: acceptable <110, borderline-high 110-129, high ≥130; non-HDL-chol: acceptable <120, borderline-high 120-144, high ≥145; HDL-chol: acceptable >45, borderline-low 40-45, low <40; and TG: acceptable <75, borderline-high 75-99, high ≥100 in ≤9 year-old children, and acceptable <90, borderline-high 90-129, and high ≥130 in 10 year-old children. The overall prevalence of borderline-high + high TG, non-HDL-chol, TChol, and LDL-chol was 63.0%, 44.1%, 43.5%, and 29.9%, respectively. The overall prevalence of borderline-low + low HDL-chol was 46.3%. Th...Continue Reading

References

May 1, 1991·American Journal of Epidemiology·L S WebberG S Berenson
May 1, 1987·American Journal of Physical Anthropology·S BaileyL Mata
Dec 1, 1995·The American Journal of the Medical Sciences·S S Gidding
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Mar 20, 2003·Sozial- Und Präventivmedizin·Fereidoun AziziS Moeini
Aug 3, 2006·Acta Paediatrica·Joey C EisenmannMegan Holmes
Jun 27, 2007·BMJ : British Medical Journal·Tim J ColeAlan A Jackson
Nov 14, 2007·Metabolism: Clinical and Experimental·Rosalinda Posadas-SánchezLiria Yamamoto-Kimura
Nov 5, 2008·Revista de saúde pública·Ana Carolina R VieiraGloria V Veiga
Oct 10, 2009·Therapeutics and Clinical Risk Management·Robabeh Ghergerehchi
Apr 22, 2010·JAMA : the Journal of the American Medical Association·Jean A WelshMiriam B Vos
Jul 6, 2010·Pharmacoepidemiology and Drug Safety·Jie LiJudith K Jones
Aug 17, 2010·International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity·Thomas ModéerClaude Marcus
Mar 31, 2011·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Vaughn W BarrySteven N Blair
Jun 30, 2011·European Heart Journal·UNKNOWN European Association for Cardiovascular Prevention & RehabilitationUNKNOWN ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees
Oct 18, 2011·Journal of Immigrant and Minority Health·María A Hernández-ValeroNorma Olvera
Oct 28, 2011·Revista de salud pública·Alicia N AlayónLourdes Benítez-Peña
Nov 16, 2011·Pediatrics·UNKNOWN Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, UNKNOWN National Heart, Lung, and Blood Institute
Apr 18, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul S JellingerUNKNOWN AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis
Apr 24, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul S JellingerUNKNOWN AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis
Sep 1, 2012·Pediatric Cardiology·Murat CanGorkem Mungan
Jan 29, 2013·Journal of the Academy of Nutrition and Dietetics·Ethan C KosovaAndrew A Bremer
Jul 16, 2013·Jornal de pediatria·Luciana N NobreSylvia do C C Franceschini
Apr 11, 2014·The American Journal of Clinical Nutrition·Kenneth P KellJosé R Fernández
Apr 20, 2014·The Journal of Nutrition·Dalia SternBarry M Popkin
Nov 27, 2014·Journal of Physical Activity & Health·María del Pilar Rodriguez MartinezJuan Ricardo Lopez y Taylor

❮ Previous
Next ❯

Citations

Oct 22, 2016·Journal of Pediatric Gastroenterology and Nutrition·Maria Del Mar BibiloniJosep A Tur
Feb 23, 2019·Clinical Pediatrics·Lisa HerringtonElizabeth Hisle-Gorman
Jun 21, 2019·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ashkan HabibAsadollah Habib
May 20, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Michelle TurcotteDavid Meyre
Jul 19, 2017·Scientific Reports·Sofia Moran-RamosSamuel Canizales-Quinteros
Dec 19, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tuck Seng ChengC Mary Schooling
Nov 24, 2020·American Journal of Human Biology : the Official Journal of the Human Biology Council·Larissa Michelle González-ArceLizbeth González-Herrera
Feb 15, 2021·BMC Pediatrics·Silvestre Garcia-de la PuenteTania T Vargas-Robledo
Mar 7, 2021·International Journal of Environmental Research and Public Health·Beata Bondyra-WiśniewskaAnna Harton

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.